Duloxetine Capsule, Delayed Release
Product Images NDC 50090-5940

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 50090-5940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Duloxetine Fig1)

This appears to be a graph or chart displaying the number of patients who experienced relapse over time, measured in days, during a study comparing treatment with a placebo and duloxetine. The x-axis measures the time from randomization to relapse in days, ranging from 0 to 250. The y-axis is not labeled, but likely represents the number or percentage of patients experiencing relapse. There are two lines on the chart, one for placebo and one for duloxetine, indicating the difference in relapse rates between the two treatments.*

FDA Label Image

Figure10 (Duloxetine Fig10)

This text appears to be a medication prescription for Duloxetine in doses of 60mg or 120mg to be taken once daily. The text also includes a graph measuring percent improvement in pain from a baseline, but without additional context or labels, it is not possible to provide further information.*

FDA Label Image

Figure2 (Duloxetine Fig2)

The text represents a graph showing the proportion of patients with a relapse over time after randomization and treatment with either placebo or Duloxetine. The x-axis represents the time in days, while the y-axis represents the proportion of patients with relapse. The graph shows that Duloxetine treatment decreased the proportion of patients with relapse compared to the placebo group over time.*

FDA Label Image

Figure3 (Duloxetine Fig3)

The text appears to be a table showing the percentage of patients who experienced improvement in pain from duloxetine medication in various dosages compared to a placebo. However, the format is not clear, and there is a strange line of characters at the end that does not make sense.*

FDA Label Image

Figure4 (Duloxetine Fig4)

FDA Label Image

Figure5 (Duloxetine Fig5)

The text is describing a comparison of the percentage of patients experiencing improvement with different doses of duloxetine, a medication commonly used to treat depression and anxiety. The table shows the percentages for the different treatment groups, with the twice-daily 60mg dose of duloxetine resulting in the highest percentage of patients who experienced improvement. The table also includes a section on percent improvement in pain from baseline, indicating that the medication may also be effective in treating pain symptoms.*

FDA Label Image

Figure6 (Duloxetine Fig6)

FDA Label Image

Figure8 (Duloxetine Fig8)

This text appears to be a section of a medical document discussing the use of Duloxetine, a medication used to treat symptoms of depression and anxiety. Specifically, it mentions a dosage range of 60/120 mg taken once daily and includes a chart or graph displaying percent improvement in pain from baseline. It is unclear what the numbers and symbols following the chart represent.*

FDA Label Image

Figure9 (Duloxetine Fig9)

This is a clinical trial that compares the placebo effect with duloxetine 60 mg taken once daily for pain relief, indicated by a graph showing percentage improvement in pain from the baseline. The text seems to have some errors and random characters, but the information presented suggests the purpose of the study.*

FDA Label Image

Structure (Duloxetine Structure)

FDA Label Image

Label Image (Lbl500905940)

This is a product label for a medication called BoloXetine with a strength of 60mg. It comes in a bottle with 30 delayed-release capsules and should be stored at a temperature of 77 degrees Fahrenheit. The product number is 6db2-0.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.